Finance

Beta
Lists
688163:SHA
Shanghai Serum Bio-Technology Co Ltd
CNÂ¥36.52
+0.05%
(+0.020) 1D
Jun 5, 3:00:05 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688163...
Open
CNÂ¥36.49
High
CNÂ¥37.12
Low
CNÂ¥35.55
Mkt. cap
3.95B
Avg. vol.
2.71M
Volume
1.35M
Dividend
1.04%
Quarterly dividend
CNÂ¥0.09
Ex-dividend date
May 29, 2026
P/E ratio
81.33
52-wk high
CNÂ¥43.00
52-wk low
CNÂ¥18.66
EPS
CNÂ¥0.45
No. of employees
330
Open
CNÂ¥36.49
High
CNÂ¥37.12
Low
CNÂ¥35.55
Mkt. cap
3.95B
Avg. vol.
2.71M
Volume
1.35M
Dividend
1.04%
Quarterly dividend
CNÂ¥0.09
Ex-dividend date
May 29, 2026
P/E ratio
81.33
52-wk high
CNÂ¥43.00
52-wk low
CNÂ¥18.66
EPS
CNÂ¥0.45
No. of employees
330
News stories
From sources across the web
About Shanghai Serum Bio-Technology Co Ltd
CEO-
Employees330
FoundedNov 9, 1999
Headquarters-
SectorBiotechnology
Websiteserum-china.com.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
75.20M
74.32M
21.07M
27.09M
Cost of goods sold
16.92M
14.42M
7.22M
7.41M
Cost of revenue
16.92M
14.42M
7.22M
7.41M
Research and development expenses
5.29M
4.40M
6.63M
4.80M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
19.06M
21.33M
23.05M
15.61M
Operating expense
27.57M
24.90M
28.24M
21.31M
Total operating expenses
44.49M
39.32M
35.46M
28.72M
Operating income
30.71M
35.00M
-14.40M
-1.62M
Other non operating income
-134.69K
87.75K
-86.13K
-181.42K
EBT including unusual items
33.60M
37.05M
-10.61M
420.45K
EBT excluding unusual items
32.15M
38.54M
-11.64M
525.28K
Income tax expense
4.38M
5.82M
1.81M
-146.73K
Effective tax rate
13.03%
15.70%
-17.08%
-34.90%
Other operating expenses
522.19K
642.85K
344.72K
228.77K
Net income
29.22M
31.23M
-12.42M
567.18K
Net profit margin
38.86%
42.03%
-58.97%
2.09%
Earnings per share
-
-
-
-
Interest and investment income
1.49M
3.62M
2.97M
2.37M
Interest expense
-42.02K
-40.60K
-55.02K
-39.15K
Net interest expenses
1.45M
3.58M
2.91M
2.33M
Depreciation and amortization charges
-
-
-
-
EBITDA
34.78M
39.84M
-9.75M
3.03M
Gain or loss from assets sale
-
-
-80.37K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer